N/A N=35 Treatment

Evaluation of Ocular Comfort With ISTA Tears vs Systane

Dry Eye Disease

Bottom Line

View on ClinicalTrials.gov: NCT01650584 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Oct 2020

Primary outcome: Primary: Percentage of Participants With Preference for One of the Treatments — 23; 1; 11 Participants

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: ISTA Tears (Drug); Systane (Drug)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Bausch & Lomb Incorporated
Primary completion: Dec 2012

Outcome Measures

Outcome	Result	p-value
PRIMARY Percentage of Participants With Preference for One of the Treatments	23; 1; 11	—

Summary

To assess the comfort preference of ISTA Tears vs Systane in patients with dry eye disease (DED)

Eligibility Criteria

Inclusion Criteria

OSDI >12

Exclusion Criteria

Presence of any active ocular disease other than dry eye

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01650584). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.